Target-based drug discovery for human African trypanosomiasis: selection of molecular target and chemical matter

Domaine:

healthcare

Type de record:

paper

Créateur:

Ian

Éditeur:

Cam

Hôte:

SUMMARY Target-based approaches for human African trypanosomiasis (HAT) and related parasites can be a valuable route for drug discovery for these diseases. However, care needs to be taken in selection of both the actual drug target and the chemical matter that is developed. In this article, potential criteria to aid target selection are described. Then the physiochemical properties of typical oral drugs are discussed and compared to those of known anti-parasitics.

An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases

The protozoan diseases Human African Trypanosomiasis (HAT), Chagas disease (CD), and leishmaniases s

Phenotypic Drug Discovery for Human African Trypanosomiasis: A Powerful Approach

The work began with the screening of a library of 700,000 small molecules for inhibitors of Trypanos

Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis

Abstract The protozoan parasite Trypanosoma brucei causes the fatal illness human African trypano

Design of Multi-Target Hybrid Molecules for Synergistic Therapy of Malaria and Human African Trypanosomiasis

This dataset and accompanying research article present a novel approach for the rational design of h

Vivli Data Challenge: Genomic-Phenotypic Association for AMR Drug Target Discovery

GEPHARD: Genomic-Phenotypic Association for AMR Drug Target Discovery Antimicrobial resistance (AMR

The Molecular Dynamics of <i>Trypanosoma brucei</i> UDP‐Galactose 4′‐Epimerase: A Drug Target for African Sleeping Sickness

During the past century, several epidemics of human African trypanosomiasis, a deadly disease caused